Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial.
<h4>Background</h4>There is a clinical need for therapeutic options to reduce hyperinflation associated with severe emphysema. Endobronchial Coils (coils) are nitinol devices implanted bronchoscopically under fluoroscopic guidance to re-tension the lung. We report the medium term effecti...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0122656 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850161950276714496 |
|---|---|
| author | Zaid Zoumot Samuel V Kemp Suveer Singh Stephen R Bicknell William H McNulty Nicholas S Hopkinson Ewen T Ross Pallav L Shah |
| author_facet | Zaid Zoumot Samuel V Kemp Suveer Singh Stephen R Bicknell William H McNulty Nicholas S Hopkinson Ewen T Ross Pallav L Shah |
| author_sort | Zaid Zoumot |
| collection | DOAJ |
| description | <h4>Background</h4>There is a clinical need for therapeutic options to reduce hyperinflation associated with severe emphysema. Endobronchial Coils (coils) are nitinol devices implanted bronchoscopically under fluoroscopic guidance to re-tension the lung. We report the medium term effectiveness and safety of coils in a study of patients with emphysema.<h4>Methods</h4>Forty five subjects with severe airflow obstruction and hyperinflation received bilateral sequential treatment with coils (30 day interval between treatments) as part of a randomised controlled trial with a primary endpoint 90 days after the final treatment (Clinicaltrials.gov NCT01334307). Further assessments were made at 180 and 360 days and in this study the primary outcome was the effect of coil treatment on the St. George's Respiratory Questionnaire (SGRQ) 360 days following treatment.<h4>Results</h4>At 360 days following treatment, there was an improvement in the SGRQ score of -6.1±14.0 points (p = 0.01) compared to baseline. Improvements in secondary outcomes were seen with increases in forced expiratory volume in the first second of 8.9 ±22.2% (p = 0.002) and 6-minute walking distance of 34.1±52.4m (p = 0.003). The safety profile was acceptable out to 360 days post-treatment.<h4>Conclusions</h4>Statistically and clinically meaningful benefits in quality of life, exercise capacity and pulmonary function in patients treated with coils are sustained twelve months after treatment.<h4>Trial registration information</h4>Clinicaltrials.gov NCT01334307. |
| format | Article |
| id | doaj-art-c45e6ba3edcc4d29bd37d486da1e6910 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-c45e6ba3edcc4d29bd37d486da1e69102025-08-20T02:22:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012265610.1371/journal.pone.0122656Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial.Zaid ZoumotSamuel V KempSuveer SinghStephen R BicknellWilliam H McNultyNicholas S HopkinsonEwen T RossPallav L Shah<h4>Background</h4>There is a clinical need for therapeutic options to reduce hyperinflation associated with severe emphysema. Endobronchial Coils (coils) are nitinol devices implanted bronchoscopically under fluoroscopic guidance to re-tension the lung. We report the medium term effectiveness and safety of coils in a study of patients with emphysema.<h4>Methods</h4>Forty five subjects with severe airflow obstruction and hyperinflation received bilateral sequential treatment with coils (30 day interval between treatments) as part of a randomised controlled trial with a primary endpoint 90 days after the final treatment (Clinicaltrials.gov NCT01334307). Further assessments were made at 180 and 360 days and in this study the primary outcome was the effect of coil treatment on the St. George's Respiratory Questionnaire (SGRQ) 360 days following treatment.<h4>Results</h4>At 360 days following treatment, there was an improvement in the SGRQ score of -6.1±14.0 points (p = 0.01) compared to baseline. Improvements in secondary outcomes were seen with increases in forced expiratory volume in the first second of 8.9 ±22.2% (p = 0.002) and 6-minute walking distance of 34.1±52.4m (p = 0.003). The safety profile was acceptable out to 360 days post-treatment.<h4>Conclusions</h4>Statistically and clinically meaningful benefits in quality of life, exercise capacity and pulmonary function in patients treated with coils are sustained twelve months after treatment.<h4>Trial registration information</h4>Clinicaltrials.gov NCT01334307.https://doi.org/10.1371/journal.pone.0122656 |
| spellingShingle | Zaid Zoumot Samuel V Kemp Suveer Singh Stephen R Bicknell William H McNulty Nicholas S Hopkinson Ewen T Ross Pallav L Shah Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLoS ONE |
| title | Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. |
| title_full | Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. |
| title_fullStr | Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. |
| title_full_unstemmed | Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. |
| title_short | Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. |
| title_sort | endobronchial coils for severe emphysema are effective up to 12 months following treatment medium term and cross over results from a randomised controlled trial |
| url | https://doi.org/10.1371/journal.pone.0122656 |
| work_keys_str_mv | AT zaidzoumot endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial AT samuelvkemp endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial AT suveersingh endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial AT stephenrbicknell endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial AT williamhmcnulty endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial AT nicholasshopkinson endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial AT ewentross endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial AT pallavlshah endobronchialcoilsforsevereemphysemaareeffectiveupto12monthsfollowingtreatmentmediumtermandcrossoverresultsfromarandomisedcontrolledtrial |